Importance of non-pulmonary vein triggers ablation to achieve long-term freedom from paroxysmal atrial fibrillation in patients with low ejection fraction

Heart Rhythm. 2016 Jan;13(1):141-9. doi: 10.1016/j.hrthm.2015.08.029. Epub 2015 Aug 21.

Abstract

Background: Whether ablation of non-pulmonary vein (PV) triggers after pulmonary vein antrum isolation (PVAI) improves the long-term procedure outcome in patients with paroxysmal atrial fibrillation (PAF) and left ventricular systolic dysfunction is unknown.

Objective: We sought to evaluate whether a more extensive ablation procedure improves outcomes at follow-up.

Methods: Consecutive patients with PAF refractory to antiarrhythmic drugs presenting for PVAI were prospectively studied. Patients were categorized into 2 groups: patients with left ventricular ejection fraction (LVEF) ≤35% (group I; n = 175) and patients with LVEF ≥50% (group II; n = 545). Patients in group I were further divided according to whether additional ablation of non-PV triggers was performed (group IA; n = 88) or not (group IB; n = 87). Long-term ablation success off antiarrhythmic drugs after a single procedure was analyzed.

Results: Patients in group I had more non-PV triggers than did patients in group II (69.1% vs 26.6%; P < .001). During a follow-up of 15.8 ± 4.7 months, fewer patients in group I remained free from recurrences than those in group II (53.7% vs 81.7%; P < .001). Long-term ablation success was higher in group IA than in group IB (75.0% vs 32.2%; P < .001) and similar to that in group II (75.0% vs 81.7%; P = .44). In multivariate analysis, LVEF ≤35% (hazard ratio 1.68; P = .003) and non-PV triggers (hazard ratio 3.12; P < .001) were independent predictors of recurrences.

Conclusion: In patients with PAF and left ventricular systolic dysfunction, ablation of non-PV triggers in addition to PVAI significantly improves their long-term procedure outcome.

Keywords: Atrial fibrillation; Catheter ablation; Ejection fraction; Heart failure.

Publication types

  • Clinical Trial
  • Multicenter Study

MeSH terms

  • Aged
  • Anti-Arrhythmia Agents / therapeutic use
  • Atrial Fibrillation* / diagnosis
  • Atrial Fibrillation* / physiopathology
  • Atrial Fibrillation* / surgery
  • Catheter Ablation* / adverse effects
  • Catheter Ablation* / methods
  • Electrophysiologic Techniques, Cardiac / methods
  • Female
  • Humans
  • Long Term Adverse Effects / diagnosis
  • Long Term Adverse Effects / prevention & control*
  • Male
  • Middle Aged
  • Proportional Hazards Models
  • Prospective Studies
  • Pulmonary Veins / surgery*
  • Recurrence
  • Stroke Volume
  • Treatment Outcome
  • Ventricular Dysfunction, Left* / diagnosis
  • Ventricular Dysfunction, Left* / physiopathology

Substances

  • Anti-Arrhythmia Agents